![Human Complement C4 Antibody Conjugated to FITC Conjugate](/proxy_img/aHR0cHM6Ly9tb2xlY3VsYXJkZXBvdC5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMjMvMTEvQjIwMTQ2NzAucG5n.png)
![All Products](/proxy_img/aHR0cHM6Ly9tb2xlY3VsYXJkZXBvdC5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTkvMDUvQWxsUHJvZHVjdHMtNjAweDUwOS5wbmc=.png)
Human Complement C4 Antibody Conjugated to FITC Conjugate
Catalog Number: B2014670 (50 ug)
Human Complement C4 Antibody Conjugated to FITC Conjugate is a high quality Human Complement C4 Antibody Conjugated to FITC Conjugate. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
Human Complement C4 Antibody Conjugated to FITC Conjugate
Catalog number: B2014670
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Human Complement C4 Monoclonal Antibody (FITC Conjugate)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Triolo G, Accardo-Palumbo A, Sallì L, Ciccia F, Ferrante A, Tedesco L, Sallì S, Giardina E, Pappalardo A, Licata G. Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation Clin Exp Rheumatol. 2003 Mar-Apr;21(2):225-8.
2: Carruthers JA, Ewins AR. Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor Clin Exp Immunol. 1978 Jan;31(1):38-44.
3: Cossman J, Glorioso JC, Adler R. Complement receptors: specific detection by molecular complexes J Immunol Methods. 1978;19(2-3):227-34.
4: Polenakovic M, Cukaranovic R, Savic V, Jovanovic I, Stefanovic V. Immunological studies in Balkan Endemic Nephropathy Prilozi. 2007 Jul;28(1):13-22.
5: Perkkiö M. Immunohistochemical study of intestinal biopsies from children with atopic eczema due to food allergy Allergy. 1980 Oct;35(7):573-80.
6: Perkkiö M, Savilahti E, Kuitunen P. Semi-quantitative analysis of immunoglobulins and complement fractions 3 and 4 in the jejunal mucosa in coeliac disease and in food allergy in childhood. Immunohistochemical study by light and electron microscopy Acta Pathol Microbiol Scand A. 1981 Sep;89(5):343-50.
7: Claudy AL, Ortonne JP, Trepo C, Bugnon B. [Adult papular acrodermatitis (Gianotti’s disease). Report of 3 cases] Ann Dermatol Venereol. 1977 Mar;104(3):190-4.
8: Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J Virol. 1996 Feb;70(2):1100-8.
9: Dodds AW, Law SK, Porter RR. The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6 EMBO J. 1985 Sep;4(9):2239-44.
10: Hsiung LM, Mason DW, Dodds AW. A monoclonal antibody which can distinguish between the two isotypes of human C4 Mol Immunol. 1987 Jan;24(1):91-6.
Products Related to Human Complement C4 Antibody Conjugated to FITC Conjugate can be found at Conjugates
Additional Information
Weight | 0.15 oz |
---|---|
Dimensions | 2 × 0.5 × 0.5 in |